Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Sumitomo Chemical Co ( (JP:4005) ) just unveiled an announcement.
Sumitomo Chemical announced variances between its forecasted and actual financial results for the second quarter ending March 31, 2026, with stronger than expected sales of ORGOVYX in North America and reduced expenses leading to higher core operating and net income. Additionally, the company revised its full-year forecast, anticipating continued strong performance in North America and incorporating impacts from the partial sale of shares in Petro Rabigh, which is expected to positively affect its financial outcomes.
The most recent analyst rating on (JP:4005) stock is a Hold with a Yen510.00 price target. To see the full list of analyst forecasts on Sumitomo Chemical Co stock, see the JP:4005 Stock Forecast page.
More about Sumitomo Chemical Co
Sumitomo Chemical Co., Ltd. operates in the chemical industry, offering a wide range of products including essential and green materials, pharmaceuticals, and synthetic resins. The company focuses on markets in North America and has a significant presence in the pharmaceutical sector.
Average Trading Volume: 11,778,488
Technical Sentiment Signal: Buy
Current Market Cap: Yen742.7B
See more insights into 4005 stock on TipRanks’ Stock Analysis page.